CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
immunoglobulins, intravenous +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000520
NCT00000520Phase 2Completed
CompareCT.gov

Prevention of Coronary Aneurysms in Kawasaki Syndrome

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Dec 13, 2013

In Brief

A Phase 2 clinical trial evaluating immunoglobulins, intravenous and aspirin for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To test the efficacy of intravenous gamma globulin (IVGG) in preventing coronary artery aneurysms in children with Kawasaki Syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Aneurysm, Heart Diseases, Mucocutaneous Lymph Node Syndrome
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJul 1, 1985
Study CompletionNov 1, 1989
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

immunoglobulins, intravenousdrug

aspirindrug